When is inpatient care indicated in the treatment of mold-related allergic bronchopulmonary aspergillosis (ABPA) and allergic bronchopulmonary mycosis (ABPM)?

Updated: Dec 02, 2020
  • Author: Shih-Wen Huang, MD; Chief Editor: Harumi Jyonouchi, MD  more...
  • Print

Most patients are initially monitored on an outpatient basis during diagnostic workup. Inpatient care is likely when the patients' conditions are unresponsive to adequate corticosteroid therapy. Frequent inpatient care is anticipated when patients' clinical conditions become chronic (stage lV or V). A superimposed infection notably compromises the respiratory system. Patients may require frequent, short hospital stays for pulmonary medical care. If the patient has an underlying condition, such as cystic fibrosis (CF), urgent inpatient care may be needed.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!